Cargando…
Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials
Celiac disease is a lifelong disorder for which there is currently only one known, effective treatment: a gluten-free diet. New treatment approaches have recently emerged; several drugs are in Phase 2 trials and results appear promising; however, discussion around regulatory endpoints is in its infa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423465/ https://www.ncbi.nlm.nih.gov/pubmed/25725041 http://dx.doi.org/10.1093/gastro/gov006 |